Home - Boston Life Sciences Times

Medtech

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Life Sciences Times - March 4, 2026

People on the Move

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

Biotech

Takeda, Protagonist Secure FDA Priority Review for Rusfertide in Polycythemia Vera

Real Estate

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

LATEST NEWS

Technology

WHOOP Plans to Add More Than 600 Employees in 2026 as Global Expansion Accelerates

Life Sciences Times - March 4, 2026 0

BOSTON — Wearable health technology company WHOOP announced plans to hire more than 600 employees in 2026 as it expands its global platform focused...

Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds

March 4, 2026

CordenPharma Colorado Expands Peptide Development Operations with New Lease at Boulder’s Flatiron Park

March 4, 2026

Affinia Therapeutics Receives FDA Fast Track Designation for AFTX-201 Gene Therapy for BAG3-Associated Dilated Cardiomyopathy

March 4, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

PHARMA

Pharma

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

Life Sciences Times - March 3, 2026 0

CAMBRIDGE, Mass. — Amylyx Pharmaceuticals reported fourth-quarter and full-year 2025 financial results Tuesday, highlighting progress in its late-stage avexitide program for post-bariatric hypoglycemia (PBH)...

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

March 2, 2026

Merck Unveils Late-Breaking Phase 3 Data on Doravirine/Islatravir HIV Regimen at CROI 2026

February 26, 2026

Asahi Kasei Pharma Expands Preclinical Pipeline With Global Licensing Deal for Novel Compounds

February 25, 2026

Ironwood Pharmaceuticals Reports 2025 Results, Meets Guidance and Reaffirms Strong 2026 Outlook

February 25, 2026

Medtech

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Medtech

Lucent Diagnostics, Life Line Screening Partner to Expand Community Access to Blood-Based Testing

Medtech

Allurion to Appeal NYSE Delisting Notice, Outlines Plan to Regain Compliance

Medtech

Thermo Fisher Launches New Chromogenic Culture Media to Speed Detection of Candida Infections, Including Drug-Resistant Candida auris

Real Estate

CordenPharma Colorado Expands Peptide Development Operations with New Lease at Boulder’s Flatiron Park

Life Sciences Times - March 4, 2026 0

BOULDER, Colo. — BioMed Realty announced that CordenPharma Colorado has signed a 15-year lease for a newly completed 64,000-square-foot laboratory building at Flatiron Park,...

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

February 27, 2026

BioMed Realty’s Gateway of Pacific Wins BOMA TOBY Award for Excellence in Life Science Operations

February 25, 2026

Today's Headlines

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Life Sciences Times - March 4, 20260

Medtech

WALTHAM, Mass. — Arsenal Medical announced that the first patient has been treated with its investigational device ResQFoam in the REVIVE clinical study at...